What's Going On With COVID-19 Antibody Developer Invivyd Stock On Friday?

BenzingaJan 11 01:12

Invivyd Price Target Maintained With a $9.00/Share by D. Boral Capital

Dow JonesJan 10 21:09 · Ratings

12 Health Care Stocks Moving In Friday's Pre-Market Session

BenzingaJan 10 20:05

Express News | Invivyd Inc - No Meaningful Change to Pemgarda Neutralization Activity Expected

BreakingsJan 10 20:02

Invivyd Announces Continued Neutralizing Activity of PEMGARDA (Pemivibart) Against Dominant SARS-CoV-2 Variant XEC

GlobeNewswireJan 10 20:01

Express News | Invivyd Announces Continued Neutralizing Activity of Pemgarda™ (Pemivibart) Against Dominant Sars-Cov-2 Variant Xec

BreakingsJan 10 20:01